Overview

The pharmacy landscape is growing more complex with rising drug prices, hidden fees, and recent lawsuits raising concerns for employers and plan sponsors. Critical PBM financial details — like profit margins and rebate income — have often been unclear, increasing risks for ERISA fiduciaries and clouding the true value of PBM contracts.

Join us to learn how Mercer’s plan-level Prescription Drug Data Collection (RxDC) helps you meet Consolidated Appropriations Act (CAA) filing requirements while revealing key PBM insights, including profit margins, retained rebates, and actual net drug prices.

Why attend

Kickoff 2026 with the transparency and data you need to optimize pharmacy spend:

• Compare value across PBM models and direct-to-consumer options
• Leverage benchmark data for informed decisions
• Confidently address leadership and plan member questions

Who should attend

Whether you are an HR professional, benefits manager, or business leader responsible for employee healthcare, this webinar will provide you with valuable insights and practical strategies you need to know.